Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Marthe Smedinga"'
Autor:
Eline M, Bunnik, Marthe, Smedinga, Richard, Milne, Jean, Georges, Edo, Richard, Maartje H N, Schermer
Publikováno v:
Ethics & human research, 44(6), 2-13. John Wiley & Sons Ltd.
Ethics & human research, 44(6), 2-13. John Wiley and Sons Ltd
Ethics and Human Research
Ethics & human research, 44, 6, pp. 2-13
Ethics & human research, 44, 2-13
Ethics & human research, 44(6), 2-13. John Wiley and Sons Ltd
Ethics and Human Research
Ethics & human research, 44, 6, pp. 2-13
Ethics & human research, 44, 2-13
More and more frequently, clinical trials for Alzheimer disease (AD) are targeting cognitively unimpaired individuals who are at increased risk of developing the disease. It is not always clear whether AD biomarker information should be disclosed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::234f698beba86b7bc46d1043b8325a6e
https://zenodo.org/record/7825343
https://zenodo.org/record/7825343
Publikováno v:
Journal of bioethical inquiry, 19(2), 287-297. Springer Netherlands
Journal of Bioethical Inquiry, 19, 287-297
Journal of Bioethical Inquiry, 19(2), 287-297. Springer Netherlands
Journal of Bioethical Inquiry, 19, 2, pp. 287-297
Journal of bioethical inquiry
Journal of Bioethical Inquiry, 19, 287-297
Journal of Bioethical Inquiry, 19(2), 287-297. Springer Netherlands
Journal of Bioethical Inquiry, 19, 2, pp. 287-297
Journal of bioethical inquiry
Contains fulltext : 282536.pdf (Publisher’s version ) (Closed access) An increasing number of people seek medical attention for mild cognitive symptoms at older age, worried that they might develop Alzheimer's disease. Some clinical practice guidel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9940c1ad7ef5d8c146e5f5fbb086346
https://pure.amc.nl/en/publications/should-doctors-offer-biomarker-testing-to-those-afraid-to-develop-alzheimers-dementia(74ce4b6f-48b5-4f38-b2ba-f91123b7615c).html
https://pure.amc.nl/en/publications/should-doctors-offer-biomarker-testing-to-those-afraid-to-develop-alzheimers-dementia(74ce4b6f-48b5-4f38-b2ba-f91123b7615c).html
Publikováno v:
AJOB Neuroscience, 12, 231-233
AJOB Neuroscience, 12, 4, pp. 231-233
AJOB neuroscience, 12(4), 231-233. Taylor and Francis
AJOB Neuroscience, 12(4), 231-233. Taylor and Francis Inc.
AJOB Neuroscience, 12, 4, pp. 231-233
AJOB neuroscience, 12(4), 231-233. Taylor and Francis
AJOB Neuroscience, 12(4), 231-233. Taylor and Francis Inc.
McKeown and colleagues (2021) argue that an early intervention (EI) approach to Alzheimer’s disease (AD) undermines the distinction between primary and secondary prevention (McKeown, Malhi, and Sin...
An increasing number of people seek medical attention for mild cognitive symptoms at older age, worried that they might develop Alzheimer’s disease. Some clinical practice guidelines suggest offering biomarker testing in such cases, using a brain s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2659::5989665363ac8676b63f0fec652318d2
https://zenodo.org/record/6446253
https://zenodo.org/record/6446253
Publikováno v:
Journal of Neurology, 268(2), 724-733. D. Steinkopff-Verlag
Journal of Neurology
Journal of neurology, 268(2), 724-733. D. Steinkopff-Verlag
Journal of Neurology, 268, 724-733
Journal of Neurology, 268, 2, pp. 724-733
Journal of Neurology
Journal of neurology, 268(2), 724-733. D. Steinkopff-Verlag
Journal of Neurology, 268, 724-733
Journal of Neurology, 268, 2, pp. 724-733
Contains fulltext : 235700.pdf (Publisher’s version ) (Open Access) Parkinson's disease (PD) research is beginning to focus on early disease modification and prevention. The therapeutic pipeline includes a growing range of pharmacological intervent
Autor:
Herrer Abdulrahman, Marthe Smedinga, Marcel M. Verbeek, Catharina J.M. Klijn, Edo Richard, Marieke Perry
Publikováno v:
Journal of Alzheimer's Disease, 87, 2, pp. 807-816
Journal of Alzheimer's Disease, 87(2), 807-816. IOS Press
Journal of Alzheimer's Disease, 87, 807-816
Journal of Alzheimer's Disease, 87(2), 807-816. IOS Press
Journal of Alzheimer's Disease, 87, 807-816
Contains fulltext : 251457.pdf (Publisher’s version ) (Open Access) BACKGROUND: Sporadic cerebral amyloid angiopathy (sCAA) research of the past decade has increasingly focused on developing biomarkers that allow for an earlier and more accurate sC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db0c85e780223c7b82b9d9a55d2bac27
Publikováno v:
Journal of Alzheimer's Disease, 79, 2, pp. 917-927
Journal of Alzheimer's Disease
Journal of Alzheimer's Disease, 79(2), 917-927. IOS Press
Journal of Alzheimer's Disease, 79(2), 917-927. IOS Press BV
Journal of Alzheimer's Disease, 79, 917-927
Journal of Alzheimer's Disease
Journal of Alzheimer's Disease, 79(2), 917-927. IOS Press
Journal of Alzheimer's Disease, 79(2), 917-927. IOS Press BV
Journal of Alzheimer's Disease, 79, 917-927
Contains fulltext : 231791.pdf (Publisher’s version ) (Open Access) BACKGROUND: Hope for future treatments to prevent or slow down dementia motivates researchers to strive for ever-earlier diagnoses of Alzheimer's disease (AD) based on biomarkers,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1be11e35eed5f82dd19e867448dae04
https://hdl.handle.net/2066/231791
https://hdl.handle.net/2066/231791
Publikováno v:
Gerontologist, 61, 746-755
The Gerontologist
Gerontologist, 61(5), 746-755. Oxford University Press
Gerontologist, 61, 5, pp. 746-755
The Gerontologist
Gerontologist, 61(5), 746-755. Oxford University Press
Gerontologist, 61, 5, pp. 746-755
Background and Objectives The meaning of Alzheimer’s disease (AD) is changing in research. It now refers to a pathophysiological process, regardless of whether clinical symptoms are present. In the lay literature, on the other hand, AD is understoo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec27c9655998ae96c575619a276f23a0
http://hdl.handle.net/2066/236963
http://hdl.handle.net/2066/236963
Publikováno v:
Journal of Bioethical Inquiry. 19:299-299
Publikováno v:
Journal of bioethical inquiryReferences. 19(2)
An increasing number of people seek medical attention for mild cognitive symptoms at older age, worried that they might develop Alzheimer's disease. Some clinical practice guidelines suggest offering biomarker testing in such cases, using a brain sca